AM Squared’s West Pharmaceutical WST Stock Holding History

AM Squared’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$32.9K	–	103
2024 Q2	$32.9K	Hold	100	–	–	0.08%	63
2024 Q1	$39.6K	Buy	+100	New	+$37K	0.1%	29

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AM Squared's WST Position: Q3 2024 in Review

AM Squared sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 100 shares — an estimated $32.9K sold.

AM Squared first reported a position in WST in Q1 2024 and held it in 2 quarters. The position peaked at $39.6K in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

AM Squared reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
AM Squared sold 100 West Pharmaceutical shares in Q3 2024, an estimated $32.9K.
AM Squared first reported a position in West Pharmaceutical in Q1 2024 and held it in 2 quarters.
AM Squared's West Pharmaceutical position peaked at $39.6K in Q1 2024.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.